Cardinal Capital Management Inc (Canada)’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-2,250
| Closed | -$252K | – | 69 |
|
2025
Q1 | $252K | Sell |
2,250
-10,325
| -82% | -$1.16M | 0.01% | 68 |
|
2024
Q4 | $1.16M | Sell |
12,575
-7,673
| -38% | -$709K | 0.04% | 59 |
|
2024
Q3 | $1.7M | Sell |
20,248
-170,135
| -89% | -$14.3M | 0.07% | 49 |
|
2024
Q2 | $13.1M | Buy |
190,383
+1,163
| +0.6% | +$79.8K | 0.5% | 47 |
|
2024
Q1 | $13.9M | Buy |
189,220
+8,930
| +5% | +$654K | 0.62% | 41 |
|
2023
Q4 | $14.6M | Sell |
180,290
-2,385
| -1% | -$193K | 0.69% | 38 |
|
2023
Q3 | $13.7M | Buy |
182,675
+555
| +0.3% | +$41.6K | 0.71% | 38 |
|
2023
Q2 | $14M | Sell |
182,120
-1,635
| -0.9% | -$126K | 0.7% | 38 |
|
2023
Q1 | $15.2M | Sell |
183,755
-1,555
| -0.8% | -$129K | 0.83% | 35 |
|
2022
Q4 | $15.9M | Buy |
185,310
+4,410
| +2% | +$379K | 0.9% | 34 |
|
2022
Q3 | $11.2M | Buy |
180,900
+4,360
| +2% | +$269K | 0.68% | 37 |
|
2022
Q2 | $10.9M | Sell |
176,540
-89,830
| -34% | -$5.55M | 0.6% | 39 |
|
2022
Q1 | $15.8M | Buy |
266,370
+24,230
| +10% | +$1.44M | 0.77% | 36 |
|
2021
Q4 | $17.6M | Buy |
242,140
+16,600
| +7% | +$1.21M | 0.82% | 34 |
|
2021
Q3 | $15.8M | Buy |
225,540
+8,360
| +4% | +$584K | 0.86% | 32 |
|
2021
Q2 | $15M | Buy |
217,180
+19,537
| +10% | +$1.35M | 0.81% | 35 |
|
2021
Q1 | $12.8M | Buy |
197,643
+40,708
| +26% | +$2.63M | 0.75% | 35 |
|
2020
Q4 | $9.14M | Buy |
156,935
+12,385
| +9% | +$722K | 0.56% | 40 |
|
2020
Q3 | $9.13M | Buy |
144,550
+21,645
| +18% | +$1.37M | 0.65% | 39 |
|
2020
Q2 | $9.46M | Buy |
122,905
+24,500
| +25% | +$1.88M | 0.8% | 34 |
|
2020
Q1 | $7.36M | Buy |
+98,405
| New | +$7.36M | 0.61% | 36 |
|